What is CERO's current stock price?

CERO (CERo Therapeutics Holdings, Inc.) is currently trading at $0.01 with a market cap of $451.1K.

What sector is CERo Therapeutics Holdings, Inc. in?

CERo Therapeutics Holdings, Inc. (CERO) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

CERO CERo Therapeutics Holdings, Inc.

OTCHealthcare

$0.0100+0.00%ClosedMarket Cap: $451,124

As of 2026-08-24 16:00

Why CERO matters now

CERo Therapeutics Holdings, Inc. (CERO) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.01 with +0.00% on the session and $451.1K in market capitalization.

The latest indexable market news headline is "CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following Treatment" from GlobeNewsWire.

Latest News

CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following TreatmentGlobeNewsWire · 2026-06-15

CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following TreatmentGlobe News Wire · 2026-06-15

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

OTC

Beta

0.16

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.